Madrigal Pharmaceuticals Inc (MDGL)

Operating Expenses

$380.55M

Quarterly · Period ending: · USD

MDGL logo

MDGL Operating Expenses

Latest reported$380.55M
MDGL Quarterly Operating Expenses ($5.63M → $380.55M)
High-resolution chart · PNG

MDGL operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
380,553,000
377,213,000
356,244,000
383,121,000
250,939,000
212,048,000
166,871,000
176,327,000
176,539,000
152,037,000
117,176,000
98,534,000
86,450,000
78,336,000
85,299,000
80,412,000
70,273,000
57,587,000
64,601,000
63,160,000
61,742,000
52,979,000
59,555,000
58,786,000
50,327,000
38,005,000
29,954,000
24,167,000
22,676,000
18,091,000
14,429,000
11,309,000
7,802,000
7,046,000
8,851,000
8,628,000
8,431,000
6,075,000
7,682,794
13,959,518
3,695,000
6,447,000
10,380,000
17,394,000
19,504,000
20,332,000
19,894,000
19,449,000
21,701,000
22,907,000
23,444,000
21,794,000
22,063,000
20,258,000
17,703,000
14,539,000
14,134,000
14,712,000
13,662,000
13,882,000
13,363,000
12,109,000
12,402,000
13,614,000
12,404,000
13,281,000
11,660,000
12,233,000
13,103,000
26,709,000
26,501,000
27,723,000
22,316,000
19,783,000
16,343,000
15,394,000
17,466,000
17,012,000
13,005,000
15,382,000
-14,928,000
-14,928,000
-15,492,000
-26,686,000
-26,686,000
18,498,000
5,625,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.